FOXO Technologies Inc.

FOXOW ·Healthcare, Diagnostics & Research, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Revenue $27.5K $7.2K $110.3K $10.0K $12.0K $13.0K $418.0K $14.0K
Cost of Revenue — — $37.0K $70.0K $12.0K $13.0K $251.0K $14.0K
Gross Profit — — $73.3K $-60.0K $0 $0 $167.0K $14.0K
Gross Margin — — 66.5% -600.0% 0.0% 0.0% 40.0% 100.0%
Operating Expenses
Research & Development $103.1K $165.4K $-24.6K $283.0K $333.0K $309.0K $887.0K $558.0K
SG&A Expense $1.5M $987.9K $4.3M $4.7M $4.0M $6.3M $8.6M $8.3M
Operating Income $-1.6M $-1.2M $-3.7M $-3.5M $-7.6M $-7.4M $-20.9M $-8.8M
Operating Margin -5,785.7% -16,416.0% -3,339.9% -35,070.0% -63,375.0% -56,861.5% -4,990.7% -62,950.0%
Interest Expense $541.2K $42.0K $198.7K $148.0K $492.0K $225.0K $190.0K $424.0K
Pretax Income $-2.2M $-1.5M — $-3.7M $-11.3M — — $41.0M
Income Tax Expense — — — — — — — —
Net Income $-2.2M $-1.5M $-3.9M $-3.7M $-11.3M $-7.6M $-18.3M $-41.0M
Net Margin -7,872.7% -20,946.9% -3,498.5% -36,600.0% -94,108.3% -58,761.5% -4,383.5% -293,042.9%
EPS (Basic) — — — — — — — —
EPS (Diluted) — — — — — — — —
Shares Outstanding (Basic) — — — — — — — —
Shares Outstanding (Diluted) — — — — — — — —
Dividends Per Share — — — — — — — —
← Newer Page 2 of 3 Older →